介孔二氧化硅纳米颗粒作为核酸细胞内递送及后续治疗应用的载体
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.
作者信息
Cha Wenzhang, Fan Rengen, Miao Yufeng, Zhou Yong, Qin Chenglin, Shan Xiangxiang, Wan Xinqiang, Li Jinbo
机构信息
Department of General Surgery, Yancheng City No. 1 People's Hospital, Yancheng 224001, China.
Department of Medical Oncology, Yancheng City No. 1 People's Hospital, Yancheng 224001, China.
出版信息
Molecules. 2017 May 11;22(5):782. doi: 10.3390/molecules22050782.
Nucleic acids, including DNA, microRNA (miRNA), small interfering RNA (siRNA), and antisense oligonucleotide (ASO), are powerful gene regulators, which have been demonstrated as promising drug candidates for therapeutic treatments. Nevertheless, poor cellular membrane permeability and serum stability have greatly hindered the applications of nucleic acids in biomedicine. To address these issues, associate carriers that can encapsulate and protect nucleic acids are urgently required. Mesoporous silica nanoparticles (MSNs or MSNPs), which are nanomaterials with excellent biocompatibility, large surface area for functionalization, and tunable pore size for encapsulating different cargos, are emerging as novel and ideal biomaterials for different biomedical applications. In this review paper, we focus on the applications of MSNs in nucleic acid delivery and nucleic acid-guided therapeutic treatments. General strategies for the preparation of nucleic acid-MSN complexes will be firstly introduced, followed by a summary of recent applications of MSNs in nucleic acid delivery and nucleic acid-guided therapeutics.
核酸,包括脱氧核糖核酸(DNA)、微小核糖核酸(miRNA)、小干扰核糖核酸(siRNA)和反义寡核苷酸(ASO),是强大的基因调节剂,已被证明是有前景的治疗性候选药物。然而,较差的细胞膜通透性和血清稳定性极大地阻碍了核酸在生物医学中的应用。为了解决这些问题,迫切需要能够封装和保护核酸的载体。介孔二氧化硅纳米颗粒(MSNs或MSNPs)是具有优异生物相容性、大功能化表面积以及可调节孔径以封装不同货物的纳米材料,正作为用于不同生物医学应用的新型理想生物材料而兴起。在这篇综述论文中,我们聚焦于MSNs在核酸递送和核酸引导治疗中的应用。首先将介绍制备核酸 - MSN复合物的一般策略,随后总结MSNs在核酸递送和核酸引导治疗中的近期应用。